Lumeda, a medical technology company, announced the closing of its Series A financing. The round was led by Connecticut Innovations, with participation from Cycle Venture Partners and brings the total amount raised to date to $5.3M. Both firms, along with angel investors, participated in the company's Seed funding round in early 2020.

Lumeda is a medical technology company advancing PDT to treat NSCLC and other thoracic malignancies. The company applies advanced photonics and proprietary artificial intelligence (AI) software to automate and digitize PDT light delivery to improve physician control, reduce procedure time and enable data capture for treatment planning. The multidisciplinary Lumeda team has decades of experience in the photonics industry, with expertise in systems engineering and commercialization of new technology.